Nearly $100 billion in deposits pulled from banks; officials call system ‘sound and resilient’
Regulators again assured the public that the system is safe, as data showed customers pulled nearly $100 billion in deposits.
Wyoming abortion ban blocked due to Obamacare-era amendment
Abortion is legal in Wyoming again thanks to a state constitutional amendment pushed by conservatives opposed to Obamacare more than a decade ago.
Follow this rule of thumb to avoid taking on too much student debt, college experts say
As students weigh which school to attend, making sure they won’t need to borrow too much is key, experts say.
Biden and Trudeau promote strength of democratic alliance on heels of Putin, Xi meeting
President Biden met with Canadian Prime Minister Trudeau days after Chinese President Xi traveled to Moscow to meet with Russian President Putin.
Carl Icahn claims Illumina directors got extra insurance to close ‘disastrous’ $7.1 billion Grail deal
Carl Icahn claims Illumina directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of Grail
Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says
People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
Sam Altman didn’t take any equity in OpenAI, report says
OpenAI co-founder and CEO Sam Altman didn’t take an equity stake in the company when it added the for-profit OpenAI LP entity in 2019, according to Semafor.
Can Costco maintain its edge over Sam’s Club?
Sam’s Club is betting that investments in robotics and technology can help it better engage with budget-conscious shoppers and take on its competitors.
Activision increased representation of women and non-binary people by 2 percentage points as it faces 2025 goal
Activision increased the representation of women and non-binary by 2 percentage points from November 2021 to December 2022, according to data shared with CNBC.
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
Sanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say “exceeded expectations.”
